Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKesson
Johnson and Johnson
Fuji
US Department of Justice
Fish and Richardson
Baxter
Chinese Patent Office
Merck

Generated: November 12, 2018

DrugPatentWatch Database Preview

Clindamycin palmitate hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clindamycin palmitate hydrochloride and what is the scope of clindamycin palmitate hydrochloride patent protection?

Clindamycin palmitate hydrochloride is the generic ingredient in two branded drugs marketed by Pharmacia And Upjohn, Amneal Pharms, Aurobindo Pharma Ltd, Heritage Pharms Inc, Lyne, Mylan Pharms Inc, Orit Labs Llc, and Paddock Llc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty-five drug master file entries for clindamycin palmitate hydrochloride. Eleven suppliers are listed for this compound.

Summary for clindamycin palmitate hydrochloride
Pharmacology for clindamycin palmitate hydrochloride
Synonyms for clindamycin palmitate hydrochloride
[(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate;hydrochloride
[(2R,4S,5R)-6-[2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] hexadecanoate hydrochloride
[6-[2-chloro-1-[(1-methyl-4-propyl-pyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] hexadecanoate hydrochloride
25507-04-4
34850-73-2
35208-55-0 (Parent)
6-{2-chloro-1-[(1-methyl-4-propylpyrrolidin-2-yl)formamido]propyl}-4,5-dihydroxy-2-(methylsulfanyl)oxan-3-yl hexadecanoate hydrochloride
AB2000687
AB51459
AC-8823
AC1L1OVK
AKOS015963324
AKOS030242182
AN-7626
C-23416
C34H63ClN2O6S.HCl
C34H64Cl2N2O6S
CAS-25507-04-4
CHEBI:34647
CHEMBL1200632
Cleocin Pediatric
Cleocin pediatric (TN)
CLINDALYCIN PALMITATE HYDROCHLORIDE
Clindamycin 2-palmitate hydrochloride
Clindamycin palmitate HCl
Clindamycin palmitate hydrochloride (JAN/USP)
Clindamycin Palmitate Hydrochloride [USAN:JAN]
Clindamycin palmitate hydrochloride [USAN:USP:JAN]
Clindamycinpalmitatehydrochloride
CTK8F8720
D01990
DSSTox_CID_28660
DSSTox_GSID_48734
DSSTox_RID_82930
DTXSID3048734
J-016026
L-threo-alpha-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-2-hexadecanoate, monohydrochloride, (2S-trans)-
L-THREO-ALPHA-D-GALACTO-OCTOPYRANOSIDE, METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-[[(1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL]AMINO]-1-THIO-,2-HEXADECANOATE, MONOHYDROCHLORIDE, (2S-TRANS)-
LS-174102
METHYL 7-CHLORO-6,7,8-TRIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-L-THREO-ALPHA-D-GALACTO-OCTOPYRANOSIDE 2-HEXADECANOATE MONOHYDROCHLORIDE
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2-palmitate monohydrochloride
MolPort-003-983-293
MolPort-028-599-793
NCGC00185773-02
NSC-759141
NSC759141
O721
Pharmakon1600-01505470
s2596
SCHEMBL41416
Tox21_113175
U 25179E
U-25,179 E
UNII-VN9A8JM7M7
VN9A8JM7M7

US Patents and Regulatory Information for clindamycin palmitate hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paddock Llc CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 090902-001 Jul 7, 2010 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Amneal Pharms CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 203513-001 Mar 13, 2014 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Pharms Inc CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 203063-001 May 25, 2016 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Heritage Pharms Inc CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 207047-001 May 11, 2018 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
McKesson
Johnson and Johnson
Fuji
US Department of Justice
Fish and Richardson
Baxter
Chinese Patent Office
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.